Biogen is committed to meeting all global transparency requirements, including the Physician Payments Sunshine Act in the United States and the European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure Code in the European Union. As is our obligation, we record all transfers of value to healthcare professionals and organisations and report where required under applicable local codes and laws.

We take care to ensure that the data that we submit is as detailed, comprehensive and clear as possible. This information is an important part of our ongoing collaboration with the healthcare community. Ultimately, the data we submit today can benefit patients in the future.

In New Zealand, as a member of Medicines New Zealand, Biogen endorses the Medicines New Zealand Code of Practice. This Code does not currently require the reporting of transfers of value by individual Healthcare Professionals.